SOX6 Suppresses the Development of Lung Adenocarcinoma by Regulating Expression of P53, P21 , Cyclin D1 and β-catenin
Overview
Affiliations
The Sry-related high-mobility group box6 (SOX6) has been implicated in the development of cancer, but its role in lung cancer is incompletely understood. Here, we report that SOX6 expression is frequently down-regulated in lung adenocarcinoma tissues. Moreover, SOX6 can inhibit the proliferation and invasion of lung adenocarcinoma cells, which may occur through cell cycle arrest at G1/S due to up-regulation of p53 and p21 and down-regulation of cyclin D1 and β-catenin. Univariate and multivariate analyses revealed that the expression of SOX6 is significantly associated with patient disease-related survival and is an independent prognostic factor for lung adenocarcinoma. These data suggest that SOX6 may act as a suppressor of lung adenocarcinoma.
Zheng H, Liu M, Shi S, Huang H, Yang X, Luo Z Mol Oncol. 2024; 18(5):1327-1346.
PMID: 38383842 PMC: 11076992. DOI: 10.1002/1878-0261.13613.
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.
Song B, Yang P, Zhang S Cancer Commun (Lond). 2024; 44(3):297-360.
PMID: 38311377 PMC: 10958678. DOI: 10.1002/cac2.12520.
-Related Transcription Factors in Head and Neck Squamous Cell Carcinomas: In Silico Based Analysis.
Kolenda T, Graczyk Z, Zarska B, Losiewski W, Smolibowski M, Wartecki A Curr Issues Mol Biol. 2023; 45(12):9431-9449.
PMID: 38132438 PMC: 10742289. DOI: 10.3390/cimb45120592.
The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma.
Anbiyaee O, Moalemnia A, Ghaedrahmati F, Khombi Shooshtari M, Khoshnam S, Kempisty B BMC Nephrol. 2023; 24(1):380.
PMID: 38124072 PMC: 10731893. DOI: 10.1186/s12882-023-03438-1.
Tate G Acta Histochem Cytochem. 2023; 56(3):55-58.
PMID: 37425095 PMC: 10323198. DOI: 10.1267/ahc.23-00012.